Micropep Technologies, in partnership with Corteva, Inc. through its Corteva Catalyst platform, announced a multi-year research and development collaboration. The agreement focuses on co-developing next-generation peptide-based biocontrol solutions, including biofungicides and disease control products. This strategic alliance represents a major validation of Micropep’s proprietary Krisalix™ AI discovery platform.
As part of the agreement, Corteva, which invested in Micropep in 2024, will hold exclusive rights to apply a defined peptide library globally across biocontrol and biofungicide applications. This collaboration aims to harness novel micropeptides to develop affordable and sustainable tools that complement existing crop protection solutions. The goal is to provide growers with additional options to manage crop diseases effectively.
This partnership allows Corteva to advance sustainable agriculture by strategically leveraging its R&D capabilities and Micropep's innovative peptide technology. The collaboration is expected to accelerate the delivery of eco-friendly solutions that meet growers’ needs while promoting environmental stewardship.
The content on BeyondSPX is for informational purposes only and should not be construed as financial or investment advice. We are not financial advisors. Consult with a qualified professional before making any investment decisions. Any actions you take based on information from this site are solely at your own risk.